Pre-Treatment FDG PET Bone Marrow (BM) Uptake and Disease Involvement. Can Semiquantitative Measures Discriminate Between A Normal, Hypercellular or Infiltrated Bone Marrow?

R Ahmed¹, Xiaopan Yao², Y Fourzali³ and M Djekidel^4*

¹PGY4: Nuclear Medicine, Yale University School of Medicine, USA

²Department of Diagnostic radiology, Yale University School of Medicine, USA

³Associate Director, Biostatistics Shared Resource; Yale Cancer Center, USA

⁴Assistant Professor, Section of Medical Oncology; Yale School of Medicine, USA

^*Corresponding Author: M Djekidel, Assistant Professor in Diagnostic Radiology; Fellowship Director for Nuclear Radiology, Yale University School of Medicine, Yale Cancer Center, USA, Fax: 203 200 5170 Email: